Published in

Wiley, Diabetes, Obesity and Metabolism, 6(19), p. 831-841, 2017

DOI: 10.1111/dom.12889

Links

Tools

Export citation

Search in Google Scholar

Novel oral glucose-lowering drugs are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes

Journal article published in 2017 by Thomas Nyström, Johan Bodegard ORCID, David Nathanson, Marcus Thuresson, Anna Norhammar ORCID, Jan W. Eriksson ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO